Patients and methods: A clinicalinterventional study on70patients with stage IV NSCLC divided into 2 groups: treated with navelbin-cisplatin (35 patients) or paclitaxel-cisplatin (35 patients) at the Department of Oncology and Palliative Care, Hanoi Medical University Hospital from 01/2014 to 11/2020.